RESPIRATORY Flashcards

1
Q

severity of airflow obstruction can be graded according to

A

predicted FEV1 following the use of bronchodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

severity of airflow obstruction, stages

A

FEV1 > 80% stage 1 or mild COPD

FEV1 50–79% stage 2 or moderate COPD

FEV1 30–49% stage 3 or severe COPD

FEV1 < 30% stage 4 or very severe COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

appropriate tool to use for the annual review of asthma in a child aged four years

A

Childhood Asthma Control Test (or Mini Asthma Quality of Life Questionnaire or Paediatric Asthma Quality of Life Questionnaire)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

clinical feature is MOST likely to suggest an alternative diagnosis to chronic obstructive pulmonary disease (COPD)

A

Haemoptysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

assessment of patients for LTOT should include the measurement of arterial blood gases when

A

two occasions at least three weeks apart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the threshold NUMBER of exacerbations per year, if any, after which long-term antibiotics are recommended for treating adult bronchiectasis?

A

3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If inhaled corticosteroids are not controlling a person’s asthma symptoms, then NICE recommendswhat to add

A

leukotriene receptor antagonist (LTRA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If inhaled corticosteroids are not controlling a person’s asthma symptoms, then BTS/SIGN recommend

A

adding in a long-acting beta-2 agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

acute severe asthma episode is defined as any one of

A

Peak expiratory flow (PEF) 33–50% best or predicted

respiratory rate ≥ 25 breaths per minute

heart rate ≥ 110 beats per minute

inability to complete sentences in one breath

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CRB65 -RR and BP

A

RR >=30, SBP <=90, DBP <=60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

steroid and dose for ECOPD

A

pred 30mg for 5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

drugs which may cause pulmonary fibrosis

A

nitrofurantoin, methotrexate, cytotoxic drugs, amiodarone, heroine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

suspicion for lung cancer - next step

A

get urgent chest xray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

indications for urgent referral to respiratory for cancer?

A

needs to have chest xray first (CT scan indicated, or persistent haemoptysis for smokers/exsmokers age 40 or over)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

asthma would be defined as life-threatening when

A

Peak expiratory flow rate (PEFR) < 33% best or predicted

Pulse oximeter oxygen saturation < 92%

Altered conscious level

Exhaustion

Arrhythmia

Hypotension

Cyanosis

Silent chest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

age when LTRA is added after SABA

A

2-5 years old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

treatment for pseudomonas in bronciectasis

A

cipro for 7-14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

NICE) advises that an urgent chest X-ray should be considered to assess for lung cancer in people aged 40 years or over with any of the following

A

Persistent or recurrent chest infection

Finger clubbing

Supraclavicular lymphadenopathy or persistent cervical lymphadenopathy

Chest signs consistent with lung cancer

Thrombocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

indication of endometrial cancer and therefore pelvic ultrasound should be considered in women aged 55 years and over

A

Thrombocytosis with visible haematuria or vaginal discharge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

occupational asthma involves peak flow reading at work and at home twice each for how many weeks

A

3 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

characterised by the development of large conglomerate masses of dense fibrosis usually in the upper lung zones usually caused by methotrexate and rheumatoid arthritis

A

Progressive massive fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

how many days of antibiotic course should be started for infective exacerbations of bronchiectasis

A

7-14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

TEST recommended to confirm a diagnosis of COPD

A

Post-bronchodilator spirometry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

alternative treatment’ for her mild intermittent asthma

A

Behavioural programmes centred on breathing exercises such as the Buteyko metho

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

percentage of cases of occupational asthma is caused by sensitiser-induced disease

26
Q

why long-acting muscarinic antagonists (LAMAs) are NOT recommended for people with acute asthma

A

The onset of bronchodilation is too slow

27
Q

disease associated with non-cystic fibrosis bronchiectasis

A

Rheumatoid arthritis

28
Q

For CAP, patients can expect what to resolve in how many weeks (5x)

A

One week: the fever should have resolved
Four weeks: the chest pain and sputum production should have substantially reduced
Six weeks: the cough and breathlessness should have substantially reduced
Three months: most symptoms should have resolved but fatigue may still be present
Six months: most people will feel back to normal

29
Q

Spirometry may under-diagnose and over-diagnose what population

A

under-diagnose younger adults and over-diagnose elderly patients

30
Q

Need for LTOT in COPD is assessed by measuring ABG when

A

on two occasions, at least three weeks apart

31
Q

In COPD, Long-term oxygen should be offered to those with a partial pressure of oxygen (PaO2) of

A

< 7.3 kPa when stable or < 7.3 kPa and < 8 kPa when there is associated peripheral oedema, pulmonary hypertension, secondary polycythaemia or nocturnal hypoxaemia, or oxygen saturation levels are 92% or less breathing air

32
Q

first-line treatment for patients with progressive chronic pulmonary sarcoidosis

A

Prednisolone

33
Q

Finger clubbing is suggestive of which dieases (3x)

A

lung cancer, interstitial lung disease, or bronchiectasis. NOT COPD

34
Q

risk factors for continuing symptoms of post-acute COVID-19 (4x)

A

Older age, high BMI, female sex and asthma

35
Q

When is pulmonary rehabilitation indicated for management of COPD

A

indicated in patients who have functional impairment or an MRC dyspnoea score of 3 or above

36
Q

Basic support for patients with COPD (3x)

A

supported to stop smoking and offered a pneumococcal vaccination and an annual influenza vaccination

37
Q

Long term oxygen therapy (LTOT) should be prescribed for at least

A

15 hours a day

38
Q

high-risk CAP treatment

A

Co-amoxiclav + clarithromycin

39
Q

patient on regular low dose ICS + SABA - not working, next step?

A

Switch to MART

40
Q

Pulmonary fibrosis spirometry

A

proportionally reduced FEV1 and FVC, FEV1/FVC>70

41
Q

GOLD guidelines recommend additional investigations at the diagnosis of COPD with

A

chest x-ray, pulse oximetry and alpha-1 antitrypsin deficiency screening

42
Q

The typical COPD patient tends to present at a younger age (<45 years) with

A

lower lobe emphysema

43
Q

self-management plan option for exacerbations should be advised for asthma according to NICE

A

quadrupling inhaled corticosteroid (ICS) therapy

44
Q

staging of COPD is based on

A

FEV1 % of predicted

45
Q

Exertional saturations should only be checked in patients with

A

resting saturations of 96% and higher who have exertional symptoms such as breathlessness or light-headedness.

46
Q

NICE guidelines recommend additional investigations at the diagnosis of COPD with

47
Q

recommended management of non-cystic fibrosis bronchiectasis

A

Airway clearance techniques

48
Q

percentage of cases of occupational asthma is caused by sensitiser-induced disease?

49
Q

recommended duration of abx for bronchiectasis if indicated

50
Q

findings support a diagnosis of asthma (feno, fev1, pef)

A

eosinophil count is above the laboratory reference range

-FeNO level is 50 ppb or more.

  • if the FEV1 increase is 12% or more and 200 ml or more from the pre-bronchodilator measurement on spirometry.
  • if PEF variability (expressed as amplitude percentage mean) is 20% or more.
51
Q

antibiotic is the preferred antibiotic to reduce the number of infective exacerbations for bronchiectasis

A

azithromycin

52
Q

Patient on CPAP for OSA, DVLA reqs for renewal of licence (Group 1 and 2)

A

Group 1 - every 3 years, Group 2 - every year review

53
Q

Which has more excacerbations and by how much, COPD or ACOS

A

ACOS, three times

54
Q

should be referred for specialist assessment due to the need for further investigations

A

People with suspected occupational asthma

55
Q

latest asthma guidance states that in a patient with symptoms, what are required to diagnose asthma

A

abnormal FENO (>50ppb) or raised serum eosinophils

56
Q

first line diagnostic test for asthma for adults

A

blood eosinophils or FeNO

57
Q

first line diagnostic test for asthma for children

58
Q

suspected asthma, first line diagnostic is normal, next? Results?

A

do spirometry, FEV1 >=12% and in adults must be >=220mL increase OR FEV1 >=10% predicted

59
Q

if second line diagnostics for asthma normal or not available, what to do next and result?

A

Peak flow variability for 2 weeks. Asthma is confirmed if PEF variability >= 20%

60
Q

If Peak flow variability is normal in trying to diagnose asthma, what to do in children and asults?

A

Children: do skin prick for house or dust mite OR total IgE AND eosinophils (positive if IgE raised AND eosinophils >0.5)
Adults: bronchial challenge test

61
Q

Asthma OUT OF CONTROL if any of

A

Restricting normal activities.
Exacerbation requiring oral steroids.
Using reliever inhaler ≥3 days/week
Waking due to asthma ≥1 nights/w.